Tag Archives: Nuplazid

Number Of Nuplazid Patient Deaths Reported To FDA In Just The Past Two Years Causes Alarm In Drug Safety Circles

This Relatively New Parkinson's Disease Drug Already Been Implicated In Hundreds Of Death Cases, While Only Being On Market Since 2016   (Posted by Tom Lamb at DrugInjuryWatch.com)   Two years ago the FDA approved Nuplazid (pimaveanserin) as a new … Continue reading

Posted in Products Liability | Tagged , , , , , , , , , , , , | Leave a comment